objective Dengue virus consists of four antigenically distinct serotypes (DENV 1-4) that are transmitted to humans by Aedes aegypti and Aedes albopictus mosquitoes. In many dengue-endemic regions, co-circulation of two or more DENV serotypes is fairly common increasing the likelihood for exposure of the two vectors to multiple serotypes. We used a model system of DENV-2 and DENV-4 to investigate how prior exposure of Aedes aegypti to one DENV serotype affects its susceptibility to another serotype.
Introduction
Dengue fever is a febrile illness caused by four antigenically distinct serotypes of dengue virus (DENV 1-4, Flaviviridae: Flavivirus) that are transmitted to humans by Aedes aegypti and Aedes albopictus mosquitoes. Each of the four serotypes is composed of a phylogenetically distinct cluster of viruses called genotypes, and each genotype contains multiple distinct strains [1, 2] . Human infection with one DENV serotype confers lifelong protective immunity against that serotype while secondary infection with a different serotype increases the risk of developing life-threatening dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) [3] . This effect is partly attributed to antibody-dependent enhancement (ADE), where antibodies against one serotype increase virus replication by enhancing the binding of the other serotypes to Fck receptor-bearing cells [4] .
Before the 1950s, human infection with two or more DENV serotypes was atypical and epidemics were rare and self-limiting [5] . Recently however, exposure of humans to two or more co-circulating DENV serotypes has become fairly common resulting in frequent epidemics and severe disease [5, 6] . These changes are attributed to globalisation, unplanned urbanisation, geographic expansion of vector species and climate change [7] . At present however, our understanding of how DENV serotypes interact within the mosquito vector and potential implications for DENV epidemiology is limited [8] [9] [10] [11] . An adult female mosquito may acquire multiple viral infections by ingesting two or more viruses in a single blood meal (coinfection) or in two or more blood meals (superinfection). Additionally, mosquitoes infected with one DENV serotype through vertical or sexual transmission may acquire a second DENV serotype via a single blood meal. Because mosquitoes remain chronically infected for life, infection with two or more DENV serotypes is more likely to occur in mosquitoes than in humans. The outcomes of multiple viral infections are complex and influenced by the virus dose, genetic relatedness of interacting viruses and whether the invading viruses occur as coinfections or superinfections [9, 10, 12] . In general, the outcome of virus-virus interactions may be neutral, where the viruses have no effect on each other [13] , synergistic, where at least one virus facilitates replication or transmission of the other virus [14] , or antagonistic, where one virus benefits at the expense of the other [12] . These interactions may have major implications on arbovirus transmission and evolution.
Superinfection interference, an antagonistic interaction where an established primary viral infection prevents infected cells from becoming infected by a secondary virus [15] , is the most common outcome of virus-virus interactions. Superinfection interference is more pronounced among closely related viruses and when the interfering virus has an advantage over the secondary virus either in time or multiplicity of infection [10, [16] [17] [18] . The mechanisms responsible for superinfection interference can vary and include competition for sites of attachment, replication, viral polymerase and host factors [19] [20] [21] . The presence of one virus may also activate the mosquito innate immunity, which may enhance the midgut infection and dissemination barriers [22] [23] [24] .
To gain further insights into how interactions between DENV serotypes within the vector may influence DENV epidemiology, we investigated how prior infection of Ae. aegypti with either DENV-2 or DENV-4 affects its susceptibility to the other serotype. We tested the hypothesis that mosquito infection with one DENV serotype renders it less susceptible to the other serotype.
Materials and methods

Mosquitoes
This experiment was conducted using F 6 and F 7 progeny of Ae. aegypti mosquitoes originally collected from Key West, Florida. Eggs on papers were added to enamel pans (24 by 36 by 5 cm) with 1 l of tap water. After hatching, first-instar larvae (<24 h old) were added to 1.6 l of filtered oak infusion held in 5-l plastic containers at an initial larval density of 150 (0.09 larvae/ml) per container. The containers were maintained at 25°C and a 12:12 light: dark photoperiod. Each container was supplemented with 0.2 g and 0.1 g of larval food (1:1 albumin: yeast) on days 1 and 7 of the experiment, respectively. Every container was examined daily until all larvae had either pupated or died. Pupae were removed daily and placed into plastic vials with water until eclosion. Newly emerged adults (both males and females) from each container were housed in paperboard cages (11 cm high 9 9.5 cm diameter) and provided with 10% sucrose ad libitum.
Preparation of infectious blood meals
Aedes albopictus epithelial cells (C6/36) were maintained at 35°C in Leibovitz L-15 media (Invitrogen, Carlsbad, CA), supplemented with 10% foetal bovine serum (FBS) (Atlanta Biological, Norcross GA) and 10 lg/ml of penicillin and streptomycin (hereafter 'L-15 media') (Invitrogen, Carlsbad, CA). Confluent monolayers of C6/36 cells in T25 flasks were inoculated with 300 ll of L-15 media containing either DENV-2 strain IQT 2124 (American genotype) or DENV-4 strain P-84 at a multiplicity of infection of 0.1. Control treatment consisting of confluent monolayers of C6/36 cells inoculated with 300 ll of L-15 media without the virus was also included. Virus and control inocula were incubated for 1-h at 35°C with occasional rocking to allow virus attachment and entry. Six millilitres of L-15 media was then added to each flask for a final volume of 6.3 ml/flask and incubated for 6 days. Virus-infected and mock-infected cells and media were then harvested from the flasks and mixed with citrated bovine blood (Hemostat, Dixon, CA) in a 1:1 ratio. Aliquots of all blood meals were taken just before and after feeding trials and stored at À80°C.
Oral infection of mosquitoes
Four-to 7-day-old Ae. aegypti females that had been sugar-starved for 48 h were offered either a non-infected blood meal [25] or an infected blood meal containing either DENV-2 or DENV-4 using an artificial membrane feeding system (Hemotek, Lancashire, United Kingdom) for 45 min. After offering the first blood meal, the mosquitoes were cold-anesthetised (4°C) and blood-fed females were transferred into new paperboard cages and maintained on 10% sucrose at 28°C and 70% relative humidity. Seven days after the first blood meal, the mosquitoes were offered either a non-infected blood meal [25] or infected blood meal containing either DENV-2 or DENV-4, depending on their assigned treatment group (Table 1) . To reduce variation between experimental treatments with respect to DENV-2 and DENV-4 blood meal titres, blood meals for all experimental treatments were prepared and offered to the mosquitoes at the same time. Only a single blood-feeding opportunity was provided to the mosquitoes. Mosquitoes in the NI/ DENV-4 and DENV-2/DENV-4 treatment were given the same DENV-4 blood meal preparation. Likewise, mosquitoes in the NI/DENV-2 and DENV-4/DENV-2 treatments were given the same DENV-2 infectious blood meal at the same time (Table 1) . Following another 7-day incubation period, females were killed and the bodies and legs of each female were separately preserved at À80°C and later assayed for DENV-2 and/ or DENV-4. Due to inadvertent death of females in DENV-2/NI treatments, we repeated this portion of experiment using a new set of infectious blood meals prepared as described previously.
Determination of virus titres in infectious blood meals
To determine titres of DENV-2 and DENV-4 infectious blood meals discussed above, Vero cells were propagated in L-15 media and maintained at 37°C and 5% CO 2 . Tenfold serial dilutions of either virus in L-15 media were inoculated in triplicate on confluent Vero cell monolayers in 24-well plates and incubated at 37°C for 90 min with periodic rocking to facilitate virus adsorption. The wells were overlaid with 1 ml of 0.8% methylcellulose (Sigma-Aldrich, St. Louis, MO) diluted in warm L-15 media supplemented with 5% FBS, and 10 lg/ml of penicillin and streptomycin (Invitrogen) and incubated at 37°C for 5 days. Virus plaques were visualised by immunoperoxidase staining as previously described [26] . Antigen-stained cells were counted, and viral titres were recorded as log 10 focus-forming units per ml (ffu/ml).
Determination of mosquito infection status
The body and legs of each female mosquito were separately homogenised with a TissueLyser (Qiagen, Valencia, CA) machine in 2-ml flat-bottom vials containing a stainless steel BB and 500 ll or 300 ll of Buffer RLT with 1% b-Mercaptoethanol (Qiagen, Valencia, CA) for bodies and legs, respectively. The homogenised samples were clarified by centrifugation, and total RNA was extracted from each sample using QIAamp virus Biorobot MDx kit according to manufacturer's protocol (Qiagen, Valencia, CA). A one-step Taqman probe qRT-PCR was used to determine the infection status. For the mosquitoes exposed to single DENV serotype, simplex qRT-PCR was conducted in 96-well reaction plates. Each reaction contained 10 ll of one-step Sensifast RT-PCR master mix (Bioline, Taunton, MA), 0.2 ll of reverse transcriptase, 0.4 ll of RNase inhibitor, 1 ll of each 10 lM forward and reverse primer, 0.5 ll of 10 lM Taqman probe, 4.9 ll of nuclease-free water (Integrated DNA Technologies, Coralville IA) and 2 ll of template RNA. For the mosquitoes exposed to two DENV serotypes, duplex qRT-PCR was performed using reaction conditions similar to the simplex qRT-PCR described above except each reaction contained 1 ll of each 10 lM forward and reverse primers, 0.5 ll of each 10 lM probes for both DENV serotypes and 2.4 ll nuclease water. DENV-2 primers and probe used for this study targeted the nonstructural protein 1 portion of DENV genome; forward primer (5 0 -CATGGCCCTKGTGGC-3 0 ), reverse primer (5 0 -CCCCATCTYTTCAGTATCCCT-3 0 ) and probe (5 0 FAM-TCCTTCGTTTCCTAACAATCC-BHQ1-3 0 ). DENV-4 primers and probe targeted the membrane prM gene; forward primer (5 0 -TTGTCCTAAT GATGCTGGTCG-3 0 ), reverse primer (5 0 -TCCACCTGA GACTCCTTCCA-3 0 ) and probe (5 0 -JOE-TTCCTACTCC TACGCATCGCATTCCG-BHQ1-3 0 ) [27] . qRT-PCR reactions were conducted in a 7300 real-time PCR system (Applied Biosystems, Foster City, CA). Thermocycling conditions were 48°C for 30 min, 95°C for 5 min followed by 45 cycles of 95°C for 15 s, and 60°C for 1 min. Females with viral RNA in their bodies and legs were considered to have a disseminated infection, while those with an infected body and uninfected legs represent a non-disseminated infection. For each treatment, the midgut infection rate was calculated as the number of females with infected bodies divided by the number of mosquitoes exposed. Midgut-disseminated infection rate was calculated as the number of mosquitoes with viral RNA in their legs divided by the number of mosquitoes with infected bodies. Population-disseminated infection rate was calculated as the number of mosquitoes with viral RNA in their legs divided by the number of mosquitoes exposed.
Statistical analysis
Statistical analyses were conducted using SAS 9.3 statistical package [28] . The infection outcome of each mosquito was categorised as either infected (1) or noninfected (0) and the proportion of mosquitoes with a midgut infection, midgut-disseminated infection and the population-disseminated infection for each serotype was calculated using a maximum-likelihood categorical analyses of contingency tables (CATMOD). To account for multiple pairwise comparisons, we applied a sequential Bonferroni correction to adjust the critical P-value.
Results
DENV-2 and DENV-4 infection titres
The titres of the first DENV-2 and DENV-4 blood meals provided to the mosquitoes were determined to be 1.1 9 10 6 ffu/ml and 9.0 9 10 5 ffu/ml, respectively. The titres of the second DENV-2 and DENV-4 blood meal were determined to be 2.7 9 10 6 ffu/ml and 9.3 9 10 5 ffu/ml, respectively. DENV-2 titre for the DENV-2/NI treatment was much lower at 1.7 9 10 5 ffu/ml ( Table 1) .
Effect of DENV-4 exposure on vector susceptibility to DENV-2 infection
Treatment type had significant effect on DENV-2 midgut infection rate, midgut dissemination rate and population dissemination rate (Tables 2 and 3 ). The DENV-2 midgut infection rate of mosquitoes in the DENV-4/DENV-2 superinfection treatment (39%) was significantly lower than of mosquitoes in NI/DENV-2 treatment (67%) (v 2 = 12.16, df = 1, P < 0.0005). Similarly, significantly fewer mosquitoes developed disseminated DENV-2 infections in the DENV-4/DENV-2 superinfection treatment than the NI/DENV-2 treatment (v 2 = 10.11, df = 1, P = 0.002). DENV-2 population dissemination rate in the DENV-4/DENV-2 treatment was significantly lower than the NI/DENV-2 treatment (v 2 = 20.38, df = 1, P < 0.0001). The DENV-2 midgut infection rate of mosquitoes in the DENV-2/DENV-4 treatment was not statistically different from the DENV-2/NI treatment after adjusting for multiple comparisons (v 2 = 4.40, df = 1, P = 0.036). Likewise, the DENV-2 midgut-disseminated and population-disseminated infection rates for the DENV-2/DENV-4 superinfection treatment were not significantly different from the DENV-2/NI treatment (midgut-disseminated infection, v 2 = 0.21, df = 1, P = 0.649; population-disseminated infection, v 2 = 0.081, df = 1, P = 0.081).
Effect of DENV-2 exposure on vector susceptibility to DENV-4 infection
Although there was a trend of lower susceptibility following exposure to DENV-2, the DENV-4 midgut infection, midgut dissemination and population dissemination rates for mosquitoes in the DENV-2/DENV-4 superinfection treatment were not significantly different from the NI/ DENV-4 treatments (midgut infection, v 2 = 1.57, df = 1, Tables 2 and 3 
Variation in the replication dynamics of DENV-2 and DENV-4
When DENV-2 and DENV-4 were administered 7 days after an initial oral challenge with a non-infectious blood meal, there was no significant difference between the two serotypes in the midgut infection rate (P = 0.622), but DENV-2 had a significantly higher disseminated infection rate (P < 0.0001) and population dissemination rate (P < 0.0001), suggesting that this serotype may have a shorter extrinsic incubation period (EIP) relative to DENV-4 (Tables 2 and 3 ). Given the relatively low viral titre in the DENV-2/NI treatment (Table 1) , we did not conduct a pairwise comparison between the DENV-2/NI and DENV-4/NI treatments; however, there was no significant difference in midgut infection rate, midgut dissemination rate or population dissemination rate between the D2/D4 and D4/NI treatments (data not shown) suggesting that after a 14-day incubation period, the infection dynamics between these two serotypes are similar.
Dual infection of DENV-2 and DENV-4
Overall, 30% and 35% of mosquitoes in the DENV-4/ DENV-2 and DENV-2/DENV-4 superinfection treatments, respectively, became infected with both serotypes ( Table 2 ). The midgut dissemination rates for mosquitoes in DENV-4/DENV-2 and DENV-2/DENV-4 treatments were 28% and 0%, respectively ( Table 2) . The corresponding population dissemination rates were 9% for mosquitoes in DENV-4/DENV-2 treatment and 0% for mosquitoes in DENV-2/DENV-4 treatment ( Table 2) .
Discussion
In this study, we investigated the potential for superinfection interference between DENV-2 and DENV-4 in one of their natural vectors Ae. aegypti. We found that Ae. aegypti females infected with DENV-4 were significantly less susceptible to secondary infection with DENV-2. A similar but non-significant effect of DENV-2 exposure on Ae. aegypti susceptibility to DENV-4 was also observed.
Superinfection interference among DENVs has been demonstrated in cell culture. Infection of mosquito C6/36 cells with one DENV serotype (DENV-1, DENV-2, DENV-3 or DENV-4) rendered them resistant to superinfection with other serotypes [29] . Cultured C6/36 cells persistently infected with each of the four DENV serotypes were also resistant to heterotypic superinfection with DENV-1 or DENV-3 [16] . More recently, DENV-4 was shown to be competitively superior to DENV-2 when the two viruses were inoculated in C6/36 cells either as coinfections or superinfections [10] . Our results indicate that similar interactions occur within the mosquito vector and may be a potential mechanism contributing to competitive displacement of DENV serotypes. Little is known about superinfection interference among DENVs in mosquitoes, but insights from other mosquito-arbovirus systems suggest it is a common phenomenon. Prior infection of DENV rendered Ae. aegypti mosquitoes less susceptible and less capable of transmitting yellow fever virus [30] . Culex quinquefasciatus mosquitoes infected with either West Nile Virus (WNV) or St. Louis encephalitis were less susceptible to the virus that was introduced as a superinfection [17] . Infection of Ae. aegypti mosquitoes with a mutant Sindbis virus inhibited replication of a superinfecting wild type [31] . Conversely, there was no interference between EEEV and Western equine encephalitis in Culex tarsalis [13] .
At a glance, it appears that a mosquito infected with DENV-4 may become a less effective vector of DENV-2. However, although prior infection with DENV-4 reduced the number of mosquitoes that developed midgut and disseminated infection of DENV-2, both midgut infection rates and population dissemination rates for DENV-2 virus were at least four (range 4-6)-fold higher than those of DENV-4 when either virus was administered 7 days after oral challenge with either a non-infectious blood meal or a heterologous DENV serotype, respectively. These results combined with the higher infection and dissemination rates for DENV-4 among individuals that were incubated for 14 days (DENV-4/NI and DENV-4/ DENV-2 relative to DENV-2/DENV-4 or DENV-2/NI) suggest that DENV-2 likely had a shorter extrinsic incubation period than DENV-4, and this may have enabled it to overcome some of the deleterious effects imposed by an existing DENV-4 infection and thus attain higher dissemination rates after a 7-day incubation period. However, we did not test the effect of extrinsic incubation period on the outcomes of interactions between the two DENV serotypes and further studies are needed on this topic. The low infection and dissemination rates for DENV-2 among individuals that were challenged with DENV-2 and then provided with a non-infectious blood meal 7 days later (DENV-2/NI treatment) is an experimental artefact as the blood meal titres for this treatment were unexpectedly much lower than those of the other DENV-2 treatments.
From an epidemiological perspective, it appears that in areas where both serotypes co-circulate, DENV-2 may have a transmission advantage over DENV-4 by having a shorter extrinsic incubation period (EIP). Shorter EIP is known to confer fitness advantage among DENV-2 genotypes and to potentially contribute to clade replacement [11] . However, we studied a single strain of Ae. aegypti and a single strain of each DENV serotype which may not be a good indicator of fitness for all strains of each serotype in different populations of Ae. aegypti. Previous studies have demonstrated fitness differences among strains of a particular DENV serotype [11, 32, 33] and population differences in mosquito susceptibility to DENVs [34, 35] . Further studies using multiple strains of each serotype and multiple populations of Ae. aegypti are needed.
DENV-2 infection and dissemination rates were significantly lower when this virus was administered after DENV-4 infection relative to a non-infectious blood meal. This indicates that prior infection of DENV-4 enhanced both the midgut infection and escape barriers. We did not examine the mechanisms underlying these enhancements, but they could be due to priority effects where the first infecting virus outcompetes the superinfecting virus for host cell receptors, viral polymerase or intracellular host factors [8, [19] [20] [21] , or the induction of antiviral activity in infected mosquitoes [22, 23] . Viral infection activates several immune pathways in mosquitoes that may suppress a superinfecting virus. These include the immune deficiency pathway, the toll pathway, Janus kinase/signal transducers and activators of transcription, and RNA interference pathway [22, 23, 36] . We are in the process of examining which of these mechanisms are responsible for superinfection interference among DENV serotypes.
We administered the superinfecting DENV serotype in mosquitoes 7 days after exposure to the first infecting virus. In nature however, the time elapsed between mosquito exposure to superinfecting virus can be highly variable. Time between exposures could be a few minutes if a mosquito is disrupted before becoming fully engorged For each of the five pairwise comparisons, differences in the midgut infection rate, midgut dissemination rate and population dissemination rate for the focal serotype(s) were assessed. The focal serotype(s) are presented in bold. P values with an asterisk (*) are significant after adjusting for multiple comparisons using sequential Bonferroni adjustment.
when taking a blood meal from an infected host and then blood feeds on another host infected with a different serotype to attain full engorgement a few minutes later. This is more likely to occur if two DENV serotypes co-occur in humans at high prevalence and multiple members of a single household become infected with different DENV serotypes. Viral superinfections could also be acquired by the mosquitoes several days apart if the mosquito acquires a full blood meal from a human host infected with one DENV serotype and then acquires a second DENV serotype during a subsequent blood meal. Previous studies suggest that superinfection interference is more likely to occur as the time interval between the challenge virus and superinfecting virus increases. Aedes triseriatus mosquitoes infected with a mutant strain of La Crosse virus (LACV) became superinfected with wild-type LACV if this virus was administered within 24 h of infection with the mutant strain [37] . In contrast, the majority of mosquitoes were resistant to wild-type LACV when it was administered at 72 h and completely refractory when it was delivered 7 days after infection with the mutant strain [37] . Similar observations were made in cultured mosquito cells where competitive suppression of the superinfecting virus was more pronounced when it was introduced 6 h compared to 1 h after the challenge virus [10] . We believe that the two DENVs could be successfully transmitted if a mosquito acquires the two viruses within a shorter time interval, but further studies are necessary to clarify this.
Conclusion
Our results demonstrate that exposure of Ae. aegypti to one DENV serotype may decrease its susceptibility to a second DENV serotype, though the magnitude of suppression may be serotype specific. In particular, we found that Ae. aegypti mosquitoes infected with DENV-4 were less susceptible to superinfection with DENV-2. However, shorter extrinsic incubation period of DENV-2 relative to DENV-4 may prevent its competitive displacement by an existing DENV-4. Collectively, these findings suggest that superinfection interference among DENVs occurs within the vector but whether it leads to competitive displacement depends on the biological characteristics of interacting strains.
